• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Melanoma vaccine testing

Article

Buenos Aires, Argentina — WorldNow reports that researchers in Argentina have successfully tested a new vaccine to prevent recurrence of melanoma.

Buenos Aires, Argentina - WorldNow reports that researchers in Argentina have successfully tested a new vaccine to prevent recurrence of melanoma.

A group of 20 patients who had undergone successful surgery for melanoma were treated with a series of four vaccines over four months. After three years, 75 percent of those patients remained cancer-free.

Study of the vaccine is to continue before being presented to the Argentinian government for approval.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.